EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11974341), on January 01, 2026, and is solely responsible for the information contained therein.